David is a partner at Maverick Capital, where he is responsible for Maverick's Private Investments.
Prior to joining Maverick, David was a leading entrepreneur who specialized in health care start-ups throughout his career. He is founder and former CEO of three biotech companies in fields ranging from tools for DNA analysis to novel therapeutics (Affymetrix, GeneSoft and Corecept.)
At Maverick, he concentrates on private companies involved in deep technology research, including next-generation DNA sequencing tools, medical devices, and cloud computing for new media applications. He currently sits on the board of one public and several private companies. He is also on The RAND Corporation's Health Advisory Board.
He received his MBA from Stanford. He is a 1997 Henry Crown Fellow of The Aspen Institute and a member of the Aspen Global Leadership Network.more » « less